ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260837.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.016131602	Sensitive
ENSG00000260837.1	ABT-263 (navitoclax)	Sarcoma	0.000694542	Sensitive